33 related articles for article (PubMed ID: 12417323)
1. A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants.
Friedler A; Hansson LO; Veprintsev DB; Freund SM; Rippin TM; Nikolova PV; Proctor MR; Rüdiger S; Fersht AR
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):937-42. PubMed ID: 11782540
[TBL] [Abstract][Full Text] [Related]
2. Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue.
Wallentine BD; Wang Y; Tretyachenko-Ladokhina V; Tan M; Senear DF; Luecke H
Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):2146-56. PubMed ID: 24100332
[TBL] [Abstract][Full Text] [Related]
3. Stabilising the DNA-binding domain of p53 by rational design of its hydrophobic core.
Khoo KH; Joerger AC; Freund SM; Fersht AR
Protein Eng Des Sel; 2009 Jul; 22(7):421-30. PubMed ID: 19515728
[TBL] [Abstract][Full Text] [Related]
4. Effects of stability on the biological function of p53.
Khoo KH; Mayer S; Fersht AR
J Biol Chem; 2009 Nov; 284(45):30974-80. PubMed ID: 19700401
[TBL] [Abstract][Full Text] [Related]
5. An in silico algorithm for identifying stabilizing pockets in proteins: test case, the Y220C mutant of the p53 tumor suppressor protein.
Bromley D; Bauer MR; Fersht AR; Daggett V
Protein Eng Des Sel; 2016 Sep; 29(9):377-90. PubMed ID: 27503952
[TBL] [Abstract][Full Text] [Related]
6. Prediction of P53 mutants (multiple sites) transcriptional activity based on structural (2D&3D) properties.
Ramani RG; Jacob SG
PLoS One; 2013; 8(2):e55401. PubMed ID: 23468845
[TBL] [Abstract][Full Text] [Related]
7. ER-localized Shr3 is a selective co-translational folding chaperone necessary for amino acid permease biogenesis.
Myronidi I; Ring A; Wu F; Ljungdahl PO
J Cell Biol; 2023 Sep; 222(9):. PubMed ID: 37477900
[TBL] [Abstract][Full Text] [Related]
8. clusterMaker: a multi-algorithm clustering plugin for Cytoscape.
Morris JH; Apeltsin L; Newman AM; Baumbach J; Wittkop T; Su G; Bader GD; Ferrin TE
BMC Bioinformatics; 2011 Nov; 12():436. PubMed ID: 22070249
[TBL] [Abstract][Full Text] [Related]
9. Structure-function-rescue: the diverse nature of common p53 cancer mutants.
Joerger AC; Fersht AR
Oncogene; 2007 Apr; 26(15):2226-42. PubMed ID: 17401432
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of mutant p53: molecular mechanisms and therapeutic potential.
Selivanova G; Wiman KG
Oncogene; 2007 Apr; 26(15):2243-54. PubMed ID: 17401433
[TBL] [Abstract][Full Text] [Related]
11. A split-ubiquitin-based assay detects the influence of mutations on the conformational stability of the p53 DNA binding domain in vivo.
Johnsson N
FEBS Lett; 2002 Nov; 531(2):259-64. PubMed ID: 12417323
[TBL] [Abstract][Full Text] [Related]
12. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.
Gorina S; Pavletich NP
Science; 1996 Nov; 274(5289):1001-5. PubMed ID: 8875926
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations.
Nikolova PV; Wong KB; DeDecker B; Henckel J; Fersht AR
EMBO J; 2000 Feb; 19(3):370-8. PubMed ID: 10654936
[TBL] [Abstract][Full Text] [Related]
15. Investigating DNA Binding and Conformational Variation in Temperature Sensitive p53 Cancer Mutants Using QM-MM Simulations.
Koulgi S; Achalere A; Sonavane U; Joshi R
PLoS One; 2015; 10(11):e0143065. PubMed ID: 26579714
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
